High Point Clinical Trial Center   Report issue

For profit Phase 1
Founded: High Point NC United States (2010)

Organization Overview

First Clinical Trial
2017
NCT03105804
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Clayton A. Dehn | High Point Clinical Trial Center | High Point Clinical Trials | High Point Clinical Trials Center

Active Ingredients

Drugs in Phase 1 Trials (3)

nicotine (nicorette) (2 trials)

pitolisant (Wakix) (1 trial)

sap-001 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 1 (Phase 1)

Gout (Phase 1)

Hyperuricemia (Phase 1)

Hypoglycemia (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 3